This effect is likely exacerbated by increased BMI and visceral fat accumulation in human obesity, as the progression from WHO Class I to WHO Class II and III obesity is associated with more hypoxic, dysfunctional adipose tissue that is increasingly resistant to insulin, regardless of patient sex [33]. The gene discussed is INS; the disease is obesity disorder.